Henry Schein Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 1/6

Henry ScheinDie Gewinne des Unternehmens sind mit einer durchschnittlichen jährlichen Rate von -3.4% zurückgegangen, während in der Branche Healthcare die Gewinne wachsen. Die Umsatzerlöse sind gewachsen mit einer durchschnittlichen Rate von 6.9% pro Jahr. Henry Schein Die Eigenkapitalrendite des Unternehmens beträgt 8.1%, und die Nettomargen liegen bei 2.8%.

Wichtige Informationen

-3.4%

Wachstumsrate der Gewinne

-0.8%

EPS-Wachstumsrate

Healthcare Wachstum der Industrie	12.6%
Wachstumsrate der Einnahmen	6.9%
Eigenkapitalrendite	8.1%
Netto-Marge	2.8%
Letzte Ertragsaktualisierung	30 Mar 2024

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Aufschlüsselung der Einnahmen und Ausgaben

Wie Henry Schein Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

LSE:0L3C Einnahmen, Ausgaben und Erträge (USD Millions)
Datum	Einnahmen	Umsatz	Allgemeine und Verwaltungskosten
30 Mar 24	12,451	346	3,015
30 Dec 23	12,339	416	2,956
30 Sep 23	12,693	445	2,909
01 Jul 23	12,598	458	2,826
01 Apr 23	12,528	478	2,799
31 Dec 22	12,647	538	2,771
24 Sep 22	12,607	638	2,732
25 Jun 22	12,718	650	2,747
26 Mar 22	12,655	646	2,702
25 Dec 21	12,401	631	2,634
25 Sep 21	12,236	626	2,581
26 Jun 21	11,898	606	2,484
27 Mar 21	10,615	438	2,294
26 Dec 20	10,119	403	2,086
26 Sep 20	9,622	591	2,188
27 Jun 20	9,291	585	2,203
28 Mar 20	10,054	713	2,351
28 Dec 19	9,986	701	2,358
28 Sep 19	9,789	488	2,301
29 Jun 19	9,636	444	2,278
30 Mar 19	9,504	438	2,238
29 Dec 18	9,418	431	2,217
29 Sep 18	10,263	304	2,319
30 Jun 18	11,069	352	2,384
31 Mar 18	11,812	377	2,460
30 Dec 17	8,883	293	2,072
30 Sep 17	12,264	554	2,504
01 Jul 17	11,968	550	2,468
01 Apr 17	11,782	534	2,440
31 Dec 16	11,572	507	2,409
24 Sep 16	11,302	498	2,366
25 Jun 16	11,122	492	2,336
26 Mar 16	10,879	489	2,296
26 Dec 15	10,630	479	2,238
26 Sep 15	10,481	482	2,219
27 Jun 15	10,419	469	2,215
28 Mar 15	10,405	467	2,202
27 Dec 14	10,371	466	2,196
27 Sep 14	10,196	457	2,147
28 Jun 14	9,921	450	2,079
29 Mar 14	9,697	442	2,025
28 Dec 13	9,561	432	1,979
28 Sep 13	9,443	420	1,948
29 Jun 13	9,325	409	1,929

Qualität der Erträge: 0L3C hat hohe Qualitätseinkünfte.

Wachsende Gewinnspanne: 0L3CDie aktuellen Gewinnspannen (2.8%) sind niedriger als im letzten Jahr (3.8%).

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: 0L3CDie Erträge des Unternehmens sind in den letzten 5 Jahren um 3.4% pro Jahr zurückgegangen.

Beschleunigtes Wachstum: 0L3CDas Unternehmen hat im vergangenen Jahr ein negatives Gewinnwachstum verzeichnet, so dass es nicht mit seinem 5-Jahres-Durchschnitt verglichen werden kann.

Erträge im Vergleich zur Industrie: 0L3C hatte im vergangenen Jahr ein negatives Gewinnwachstum (-27.8%), was einen Vergleich mit dem Branchendurchschnitt Healthcare (-0.8%) erschwert.

Eigenkapitalrendite

Hohe Eigenkapitalrendite: 0L3CDie Eigenkapitalrendite des Unternehmens (8.1%) wird als niedrig angesehen.

Henry Schein Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 1/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

First quarter 2024 earnings released: EPS: US$0.72 (vs US$0.92 in 1Q 2023)

Henry Schein, Inc. to Report Q1, 2024 Results on May 07, 2024

Full year 2023 earnings released: EPS: US$3.19 (vs US$3.95 in FY 2022)

Henry Schein, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Second quarter 2023 earnings released: EPS: US$1.07 (vs US$1.17 in 2Q 2022)

Henry Schein, Inc. to Report Q2, 2023 Results on Aug 07, 2023

Recent updates

Henry Schein, Inc. Revises Earnings Guidance for the Year 2024

First quarter 2024 earnings released: EPS: US$0.72 (vs US$0.92 in 1Q 2023)

Henry Schein, Inc. to Report Q1, 2024 Results on May 07, 2024

Henry Schein, Inc. Announces Appointment of Members to the Company’S Executive Management Committee

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority interest in TriMed, Inc.

Henry Schein, Inc., Annual General Meeting, May 21, 2024

Insider recently sold US$478k worth of stock

Full year 2023 earnings released: EPS: US$3.19 (vs US$3.95 in FY 2022)

Henry Schein, Inc. Presents Comprehensive Lineup of Solutions At the 2024 Chicago Dental Society Mid Winter Meeting

Henry Schein, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire an unknown majority interest in TriMed, Inc.

Henry Schein Appoints Carole T. Faig as New Independent Director

Henry Schein Announces Receipt of Deficiency Notice From Nasdaq Regarding Requirement to Timely File Quarterly Report on Form 10-Q

Henry Schein, Inc. Provides Earnings Guidance for 2023

Henry Schein, Inc. announced delayed 10-Q filing

Henry Schein, Inc. (NasdaqGS:HSIC) completed the acquisition of an unknown majority stake in Shield HealthCare, Inc.

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year of 2023

New minor risk - Earnings quality

Second quarter 2023 earnings released: EPS: US$1.07 (vs US$1.17 in 2Q 2022)

Henry Schein, Inc. (NasdaqGS:HSIC) signed an agreement to acquire a majority stake in Shield HealthCare, Inc.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired a majority stake in Large Practice Sales LLC.

Henry Schein, Inc. to Report Q2, 2023 Results on Aug 07, 2023

Insider recently sold US$835k worth of stock

Executive VP recently sold US$1.9m worth of stock

Henry Schein, Inc. Provides Sales Guidance for the Fiscal Year 2023

First quarter 2023 earnings released: EPS: US$0.92 (vs US$1.32 in 1Q 2022)

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Regional Healthcare Group Pty Ltd.

Henry Schein, Inc. (NasdaqGS:HSIC) agreed to acquire SIN - Sistema de Implante Nacional S.A. from Southern Cross Group.

Independent Director recently sold US$148k worth of stock

Independent Lead Director recently sold US$504k worth of stock

Now 20% undervalued after recent price drop

Independent Director recently sold US$923k worth of stock

Full year 2022 earnings released: EPS: US$3.95 (vs US$4.51 in FY 2021)

Henry Schein, Inc. Reports Impairment Charge on Intangible Assets for the Fourth Quarter Ended December 31, 2022

Henry Schein, Inc. (NasdaqGS:HSIC) announces an Equity Buyback for $400 million worth of its shares.

Henry Schein, Inc. to Report Q4, 2022 Results on Feb 16, 2023

Insider recently sold US$1.2m worth of stock

Henry Schein, Inc. to Report Q3, 2022 Results on Nov 01, 2022

Henry Schein, Inc. Announces its Lineup of Products and Solutions At the American Association of Oral and Maxillofacial Surgeons (AAOMS) Annual Conference in New Orleans, La. from September 12 Through September 17

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Midway Dental Supply, Inc.

Henry Schein, Inc. Announces the Passing of Board Member E. Dianne Rekow

Second quarter 2022 earnings released: EPS: US$1.17 (vs US$1.11 in 2Q 2021)

Henry Schein, Inc. Affirms Earnings Guidance for the Full Year 2022

Henry Schein, Inc. Appoints Mark Hillebrandt as Chief Digital Revenue Officer

Henry Schein, Inc. to Report Q2, 2022 Results on Aug 02, 2022

Henry Schein, Inc. (NasdaqGS:HSIC) acquired Condor Dental Research Company SA from MCCB Holding Sarl.

Henry Schein, Inc.(NasdaqGS:HSIC) dropped from Russell 1000 Dynamic Index

Henry Schein, Inc. (NasdaqGS:HSIC) entered into a definitive agreement to acquire Condor Dental Research Company SA from MCCB Holding Sarl.

Insider recently sold US$982k worth of stock

Henry Schein, Inc. Appoints Dirk Benson as Chief Commercial Officer of North America Distribution Group

Henry Schein, Inc. Provides Earnings Guidance for the Year 2022

First quarter 2022 earnings released: EPS: US$1.32 (vs US$1.17 in 1Q 2021)

Henry Schein, Inc. to Report Q1, 2022 Results on May 03, 2022

Henry Schein Inc. Announces Executive Changes, Effective from July 1, 2022

Henry Schein Promotes Jennifer Ferrero to Corporate Secretary, Effective July 1, 2022

Executive VP recently sold US$2.0m worth of stock

Henry Schein to Showcase A Wide Portfolio of Products, Services, and Solutions During the Chicago Midwinter Dental Meeting

Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat

Henry Schein, Inc. Provides Earnings Guidance for the Year 2022

Henry Schein, Inc. Announces Lineup of New Products and Solutions At the Greater New York Dental Meeting

Third quarter 2021 earnings released: EPS US$1.16 (vs US$1.00 in 3Q 2020)

Henry Schein, Inc. Announces Not to Provide Guidance for the Year 2021

Second quarter 2021 earnings released: EPS US$1.11 (vs US$0.08 loss in 2Q 2020)

Henry Schein, Inc. (NasdaqGS: HSIC) acquired 70% stake in eAssist Dental Solutions, Inc.

Independent Director has left the company

Independent Director has left the company

Independent Director recently sold US$237k worth of stock

First quarter 2021 earnings released: EPS US$1.17 (vs US$0.91 in 1Q 2020)